Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV positive since at least 1982, he participated in the Pitt Men’s Study, a long-running AIDS research project.
Global research teams from three U.S. universities explore this HIV-tuberculosis link, thanks to a $6.2 million grant.
The social media buzz on this gene-editing technology [SLIDESHOW]
Multiple media outlets have erroneously reported the risk of HIV for bisexual men in the U.S. is comparable to the risk for heterosexual men
A reformulated vaginal microbicide gel has proved safe and well tolerated in HIV-negative women and men using it rectally.
Four research projects focusing mostly on HIV prevention have received more than $11 million from The Bill & Melinda Gates Foundation.
While many lubricants may irritate vaginal and rectal tissues, they don’t increase risk of HIV transmission—at least in test tube experiment
A consortium of researchers will share a $10 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to study the ef...
University of Pittsburgh researchers received a five year $11.8 million federal grant to develop a quickly dissolving vaginal film containing...
University of Pittsburgh researcher Ian McGowan, MD, has received two grants from the National Institutes of Health (NIH) totaling $17.5 milli...
The National Institute of Allergy and Infectious Diseases has awarded the University of Pittsburgh Graduate School of Public Health a five-yea...
As the Multicenter AIDS Cohort Study (MACS) turns 25 years old, it has much to celebrate. Leading to the identification of long-term nonprogre...
Tim Horn talks with Sharon Hillier from the University of Pittsburgh, about the latest in prevention science at latest CROI conference.
Untreated HIV may increase the risk of artery blockage and blood clots, according to new data from the international Strategies for the Manage...
Authors of study say HIV-positive people taking ARV therapy have less hardening of the arteries than HIV-positive people not on therapy.
The University of Pittsburgh’s Ian McGowan, MD, PhD, talks about the promise ofpre-exposure prophylaxis to prevent HIV transmission and...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.